cabotegravir/rilpivirine (600mg/ 900mg): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving cabotegravir/rilpivirine (600mg/ 900mg)

• Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
  NCT06507059 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

How many recruiting trials involve cabotegravir/rilpivirine (600mg/ 900mg)?

1 recruiting trial across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.